Results 191 to 200 of about 19,061 (206)
Some of the next articles are maybe not open access.
2016
Introduction to Pharmacoeconomics, W. F. McGhan Decision Modeling Techniques, M. S. Roberts and K. J. Smith Cost of Illness, R. J. G. Arnold Markov Modeling in Decision Analysis, J. R. Beck Retrospective Database Analysis, R. J. G. Arnold and S. Balu What is Cost-Minimization Analysis?, A. Haycox Cost-Effectiveness Analysis, K. J. Smith and M.
openaire +2 more sources
Introduction to Pharmacoeconomics, W. F. McGhan Decision Modeling Techniques, M. S. Roberts and K. J. Smith Cost of Illness, R. J. G. Arnold Markov Modeling in Decision Analysis, J. R. Beck Retrospective Database Analysis, R. J. G. Arnold and S. Balu What is Cost-Minimization Analysis?, A. Haycox Cost-Effectiveness Analysis, K. J. Smith and M.
openaire +2 more sources
British journal of clinical pharmacology, 2012
U predavanju je dana definicija farmakoekonomike, vrste analiza, te primjena u praksi.
openaire +2 more sources
U predavanju je dana definicija farmakoekonomike, vrste analiza, te primjena u praksi.
openaire +2 more sources
The National medical journal of India, 2004
Pharmacoeconomics focuses on the costs and benefits of drug therapy and pharmacoeconomic evaluations provide a basis for resource allocation and utilization. It is increasingly becoming important for health policy decision-making. A pharmacoeconomic evaluation may be conducted as an economic assessment incorporated into clinical trials.
Jaya, Ahuja +3 more
openaire +1 more source
Pharmacoeconomics focuses on the costs and benefits of drug therapy and pharmacoeconomic evaluations provide a basis for resource allocation and utilization. It is increasingly becoming important for health policy decision-making. A pharmacoeconomic evaluation may be conducted as an economic assessment incorporated into clinical trials.
Jaya, Ahuja +3 more
openaire +1 more source
The Journal of the Association of Physicians of India, 2002
Today, spiraling costs of medical care coupled with limited resources have led to an explosive increase in the number of pharmacoeconomic analyses being carried out. The first step in a pharmacoeconomic analysis is to measure the costs and benefits of the therapeutic regimens being compared.
N S, Sule, R P, Nerurkar, S A, Kamath
openaire +1 more source
Today, spiraling costs of medical care coupled with limited resources have led to an explosive increase in the number of pharmacoeconomic analyses being carried out. The first step in a pharmacoeconomic analysis is to measure the costs and benefits of the therapeutic regimens being compared.
N S, Sule, R P, Nerurkar, S A, Kamath
openaire +1 more source